Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors

Transfusion

Volumn 36, Issue 3, 1996, Pages 232-237

  Korelitz, J J ^a   Busch, M P ^b,c   Kleinman, S H ^d   Williams, A E ^e   Zuck, T F ^f   Gilcher, R O ^g   Ownby, H E ^h   Co Chien, H ^a   Nemo, G J ⁱ  

^a WESTAT   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Blood Centers of the Pacific   (United States)

^d UCLA MEDICAL CENTER   (United States)

^e HOLLAND LABORATORY   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g Oklahoma Blood Institute   (United States)

^h AMERICAN RED CROSS BLOOD SERVICES   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; SCREENING;

EID: 0029863028     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36396182141.x     Document Type: Article

References (41)

1. Kern JM, Croy BB. A review of transfusion-associated AIDS litigation: 1984 through 1993. Transfusion 1994;34.484-91.
2. Dodd RY, Popovsky MA. Antibodies to hepatitis B core antigen and the infectivity of the blood supply. Scientific Section Coordinating Committee. Transfusion 1991;31:443-9.
3. Leitman SF, Klein HG, Melpolder JJ, et al. Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donors. N Engl J Med 1989;321:917-24.
4. Stevens CE, Aach RD, Hollinger FB, et al. Hepatitis B virus antibody in blood donors and the occurrence on non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984;101:733-8.
5. Alter HJ, Holland PV. Indirect tests to detect the non-A, non-B hepatitis carrier state. Ann Intern Med 1984;101:859-61.
6. Koziol DE, Holland PV, Ailing DW, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A. non-B hepatitis agents in donated blood. Ann Intern Med 1986;104:488-95.
7. Zuck TF, Sherwood WC, Bove JR. A review of recent events related to surrogate testing of blood to prevent non-A, non-B posttransfusion hepatitis. Transfusion 1987;27:203-6.
8. Stevens CE, Taylor PE, Pindyck J, et al. Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. JAMA 1990;263:49-53.
9. Chambers LA, Popovsky MA. Decrease in reported post-transfusion hepatitis. Contributions of donor screening for alanine aminotransferase and antibodies to hepatitis B core antigen and changes in the general population. Arch Intern Med 1991;151:2445-8.
10. Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991;325:1325-9.
11. Donahue JG, Muñoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
12. Dodd RY, Reesink HW. Do surrogate tests improve the safety of the blood supply? Vox Sang 1995;69:280-91.
13. Douglas DD, Taswell HF, Rakela J, Rabe D. Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion 1993;33:212-6.
14. Mosley JW, Stevens CE, Aach RD, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995;35:5-12.
15. Holland PV. The effect of indirect markers of infectious disease on blood transfusion safety: overview. Program and Abstracts from the NIH Consensus Development Conference on Infectious Disease Testing for Blood Transfusions. Bethesda, MD: National Institutes of Health, January 9-11, 1995:17-20.
16. Alter HJ. Transfusion transmitted hepatitis C and non-A, non-B, non-C. Vox Sang 1994;67(Suppl 3):19-24.
17. Blajchman MA, Bull SB, Fcinman SV. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group. Lancet 1995;345:21-5.
18. Tegtmeier GE, Parton P, Alter HJ, et al. Antibodies to hepatitis B core antigen as a surrogate test for hepatitis C or a specific test for occult hepatitis B infection in blood donors. Program and Abstracts from the NIH Consensus Development Conference on Infectious Disease Testing for Blood Transfusions. Bethesda, MD: National Institutes of Health, January 9-11, 1995:57-60.
19. Le Pont F, Massari V, Jullien AM, et al. Anti-HBc testing can decrease the residual risk of transfusion-related HIV transmission by more than one third (letter). Vox Sang 1990;59:248-50.
20. Infectious disease testing for blood transfusions NIH Consensus Statement. 1995;13(1):1-27.
21. Zuck TF, Thomson RA, Schreiber GB, et al. The Retrovirus Epidemiology Donor Study (REDS): rationale and methods. Transfusion 1995;35:944-51.
22. Sayre KR, Dodd RY, Tegtmeier G, et al. False-positive human immunodeficiency virus type 1 Western blot tests in noninfected blood donors. Transfusion 1996;36:45-52.
23. Busch MP, Laycock M, Kleinman SH, et al Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Blood 1994;83:1143-8.
24. Busch MP, Dodd RY, Petersen LR. Value of anti-HBc as a surrogate marker for window phase HIV-1 infection (abstract). Transfusion 1994;34(Suppl):64S.
25. Alter HJ, Epstein JS, Swenson SG, et al. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors - an assessment of the efficacy of testing in donor screening. N Engl J Med 1990;323:1312-7.
26. Aoki SK, Finegold D, Kuramoto IK, et al. Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine. Transfusion 1993;33:362-7.
27. Dodd RY. Screening for hepatitis infectivity among blood donors. A model for blood safety? Arch Pathol Lab Med 1989;113:227-31.
28. Petersen LR, Doll LS. Human immunodeficiency virus type 1-infected blood donors: epidemiologic, laboratory, and donation characteristics. HIV Blood Donor Study Group. Transfusion 1991;31:698-703.
29. Zuck TF. Silent sequences and the safety of blood transfusions. Ann Intern Med 1988;108:895-7.
30. Jullien AM, Courouce AM, Richard D, et al. Transmission of HIV by blood from seronegative donors (letter). Lancet 1988;2:1248-9.
31. Solomon RE, VanRaden M, Kaslow RA, et al. Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV-1) infection. Am J Public Health 1990;80:1475-8.
32. Hosein B, Valinsky J, Bianco C. Profile of donors positive for HTLV-I/II (abstract). Transfusion 1989;29(Suppl):39S.
33. Taylor PE, Stevens CE, Pindyck J, et al. Human T-cell lymphotropic virus in volunteer blood donors. Transfusion 1990;30:783-6.
34. Brennan M, Runganga J, Barbara JA, et al. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. BMJ 1993;307:1235-9.
35. Schreiber GG, Busch MP, Gilcher RR, et al. Incidence rates of infectious disease markers in repeat blood donors (abstract). Transfusion 1994;34(Suppl):71S.
36. Lackritz EM, Satten GA, Kennedy MB, et al. Residual risk of transfusion-associated HIV transmission. Program and Abstracts from the National Institutes of Health Consensus Development Conference on Infectious Disease Testing for Blood Transfusions, Bethesda, MD, January 9-11, 1995:21.
37. Center for Biologics Evaluation and Research. Recommendations for donor screening with a licensed test for HIV-1 antigen. Rockville, MD: Food and Drug Administration, August 8, 1995.
38. Busch MP, Alter HJ. Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost? (editorial). Transfusion 1995;35:536-9.
39. Busch MP, Lee LLL, Satten GA, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995;35:91-7.
40. Williams AE, Sullivan MT, Busch MP, Lockwood WB. Application of an experimental anti-HBc "confirmatory" algorithm to HIV-infected and uninfected blood donors (abstract). Transfusion 1994;34(Suppl):37S.
41. Hughes W, Barr A, Dow BC, et al. A multicentre assessment of the specificity of ten anti-HBc screening tests. Transfus Med 1995;5:225-30.